Cancer Imaging is the official journal of the International Cancer Imaging Society (ICIS)
Articles
Page 21 of 22
-
Citation: Cancer Imaging 2014 14(Suppl 1):O47
-
Adrenal masses in oncology patients
Citation: Cancer Imaging 2014 14(Suppl 1):O45 -
Incidental findings in the oncology patient: pancreas and spleen
Citation: Cancer Imaging 2014 14(Suppl 1):O43 -
Pleura and lung
Citation: Cancer Imaging 2014 14(Suppl 1):O41 -
Contributions of multimodal imaging
Citation: Cancer Imaging 2014 14(Suppl 1):O40 -
Comprehensive breast MRI: an update
Citation: Cancer Imaging 2014 14(Suppl 1):O39 -
Modern technology: lowering the radiation dose for lung cancer screening
Citation: Cancer Imaging 2014 14(Suppl 1):P39 -
Lung, CNS and musculo-skeletal targeted therapy-induced toxicity: imaging features
Citation: Cancer Imaging 2014 14(Suppl 1):O38 -
Abdominal and pelvic complications of molecular targeted therapy
Citation: Cancer Imaging 2014 14(Suppl 1):O37 -
Imaging tumour response: beyond RECIST
Citation: Cancer Imaging 2014 14(Suppl 1):O36 -
Response assessment in daily practice: RECIST and its modifications
Citation: Cancer Imaging 2014 14(Suppl 1):O35 -
Beyond the image : sense and non-sense in imaging biomarkers
Citation: Cancer Imaging 2014 14(Suppl 1):O33 -
Hybrid imaging with PET/CT and PET/MR
Citation: Cancer Imaging 2014 14(Suppl 1):O32 -
Cancer imaging in the era of precision treatment: present and future
Citation: Cancer Imaging 2014 14(Suppl 1):O30 -
Role of molecular imaging in the detection of neuroendocrine tumour
Citation: Cancer Imaging 2014 14(Suppl 1):O29 -
Imaging neuroendocrine tumours of the pancreas: role of CT and MRI
Citation: Cancer Imaging 2014 14(Suppl 1):O28 -
Noncommunicating cystic pancreatic lesions (i.e. serous and mucinous cystadenoma + rare lesions)
Citation: Cancer Imaging 2014 14(Suppl 1):O27 -
Characterization and management of cystic pancreatic neoplasms communicating lesions (IPMN)
Citation: Cancer Imaging 2014 14(Suppl 1):O26 -
Session: Evaluation of lung nodules: role of PET/CT
Citation: Cancer Imaging 2014 14(Suppl 1):O25 -
Management of solid and sub-solid lung nodules
Citation: Cancer Imaging 2014 14(Suppl 1):O24 -
Utility of dual time point 18 FDG PET-CT
Citation: Cancer Imaging 2014 14(Suppl 1):P24 -
Whole-body DWI in patients with lymphoma: imaging findings, pitfalls, and limitations
Citation: Cancer Imaging 2014 14(Suppl 1):O22 -
Fast venous return in inferior mesenteric vein: a new sign for rectosigmoid carcinoma on CT
Citation: Cancer Imaging 2014 14(Suppl 1):P22 -
Complications following locoregional therapy of renal cancer
Citation: Cancer Imaging 2014 14(Suppl 1):O21 -
Locoregional therapy of renal cancer
Citation: Cancer Imaging 2014 14(Suppl 1):O20 -
Radiological characteristics of screen-detected lung cancers: predictive for histological subtype?
Citation: Cancer Imaging 2014 14(Suppl 1):P20 -
Ovarian cancer: imaging in treatment selection and planning with FIGO update
Citation: Cancer Imaging 2014 14(Suppl 1):O18 -
Diagnostic accuracy of staging of Wilms’ tumour in the era of multislice CT
Citation: Cancer Imaging 2014 14(Suppl 1):P18 -
Pediatric tumours: liver tumours
Citation: Cancer Imaging 2014 14(Suppl 1):O16 -
What the radiologist needs to know about restaging of rectal carcinoma after chemoradiation therapy
Citation: Cancer Imaging 2014 14(Suppl 1):P16 -
Neuroblastoma and nephroblastoma: an overview and comparison
Citation: Cancer Imaging 2014 14(Suppl 1):O15 -
Pediatric tumours: pseudotumour or a tumour?
Citation: Cancer Imaging 2014 14(Suppl 1):O14 -
Dynamic 18FDG PET/CT and dynamic contrast enhanced MRI of locally advanced breast cancer
Citation: Cancer Imaging 2014 14(Suppl 1):P14 -
The do’s and dont’s of liver CT and MR imaging
Citation: Cancer Imaging 2014 14(Suppl 1):O12 -
Prostate-MRI: experience of the observer and technical conditions influence the cancer detection rate
Citation: Cancer Imaging 2014 14(Suppl 1):P12 -
Clinical management of patients with complicated multifocal disease
Citation: Cancer Imaging 2014 14(Suppl 1):O11 -
Multiparametrical diffusion weighted imaging for the detection of anaplastic transformation of low-grade gliomas
Citation: Cancer Imaging 2014 14(Suppl 1):S11 -
PSMA ligands for diagnosis and therapy of prostate cancer
Citation: Cancer Imaging 2014 14(Suppl 1):O10 -
Chemotherapy response evaluation in metastatic non-small cell lung carcinoma (NSCLC) with 18F- FDG PET/CT and CT scan
Citation: Cancer Imaging 2014 14(Suppl 1):P10 -
Screening & staging of colorectal cancer
Citation: Cancer Imaging 2014 14(Suppl 1):O8 -
Staging of lung cancer CT and PET
Citation: Cancer Imaging 2014 14(Suppl 1):O6 -
MR imaging
Citation: Cancer Imaging 2014 14(Suppl 1):O5 -
Agreement of diameter- and volume-based pulmonary nodule management in CT lung cancer screening
Citation: Cancer Imaging 2014 14(Suppl 1):S4 -
Global challenges of cancer imaging: perspective from different parts of the world: Asia
Citation: Cancer Imaging 2014 14(Suppl 1):O3 -
Prostate-MRI: experience of the observer and technical conditions influence the cancer detection rate
Citation: Cancer Imaging 2014 14(Suppl 1):S2 -
Global challenges in oncologic imaging
Citation: Cancer Imaging 2014 14(Suppl 1):O1 -
Correlation between semiquantitative sonoelastography and immunohistochemistry in the evaluation of testicular focal lesions
Sonoelastography is a novel and promising imaging tool, which has been applied to breast, thyroid, and prostate tissues. The aim of this study was to evaluate focal lesions of the testes with diameters of <10 ...
Citation: Cancer Imaging 2014 14:29 -
Chest-abdomen-pelvis CT for staging in cancer patients: dose effectiveness and image quality using automated attenuation-based tube potential selection
Evaluation of automated attenuation-based tube potential selection and its impact on image quality and radiation dose in CT (computed tomography) examinations for cancer staging.
Citation: Cancer Imaging 2014 14:28 -
Endoscopic ultrasound – fine needle aspiration of 2-deoxy-2-[18F] fluoro-D-glucose avid lymph nodes seen on positron emission tomography- computed tomography –what looks like cancer may not always be so
Patients suffering from malignancies often undergo serial positron emission tomography - computed tomography (PET-CT) scans, using 2-deoxy-2-[18F] fluoro-D-glucose (FDG) for diagnosis and follow up. This principl...
Citation: Cancer Imaging 2014 14:27 -
New targeted molecular therapies for cancer: radiological response in intrathoracic malignancies and cardiopulmonary toxicity: what the radiologist needs to know
The emergence of new novel therapeutic agents which directly target molecules that are uniquely or abnormally expressed in cancer cells (molecular targeted therapy, MTT) has changed dramatically the treatment ...
Citation: Cancer Imaging 2014 14:26
Official journal of
Follow
Annual Journal Metrics
-
Citation Impact 2023
Journal Impact Factor: 3.5
5-year Journal Impact Factor: 4.3
Source Normalized Impact per Paper (SNIP): 1.416
SCImago Journal Rank (SJR): 1.227Speed 2024
Submission to first editorial decision (median days): 11
Submission to acceptance (median days): 157Usage 2024
Downloads: 976,377
Altmetric mentions: 193